Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti (Q24799349)

1

0 references

Anne C Haddix

2

0 references

Mark L Messonnier

3

0 references

Gladys Mayard

5

0 references

David G Addiss

https://scigraph.springernature.com/pub.10.1186/1475-2883-3-2

6

0 references

publication date

30 January 2004

0 references

published in

Parasites and Vectors

0 references

volume

3

0 references

issue

1

0 references

page(s)

2

0 references

exact match

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1475-2883-3-2

cites work

Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Lymphatic filariasis: economic aspects of the disease and programmes for its elimination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Filarial elephantiasis among Haitian women: social context and behavioural factors in treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

The economic burden of lymphatic filariasis in northern Ghana

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Social and economic factors and the control of lymphatic filariasis: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

The economic burden of lymphatic filariasis in India

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of bancroftian filariasis: comparison of four strategies in Tanzania

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=356926

Estimated costs of acute adenolymphangitis to patients with chronic manifestations of bancroftian filariasis in India

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14754463

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/14754463